2 Topic Commentaries

Dual Therapy for Myopia Control

Dual Therapy for Myopia Control

• 

  Mark Rallo, OD

  Pediatric Optometry

  •

  John F. Hardesty, MD Department of Ophthalmology & Visual Sciences, Washington University School of Medicine in St. Louis

  We are very excited to hear about the recent FDA approval of Stellest lenses. Progressive myopia is a real concern among pediatric ophthalmologists and optometrists. Not only does progressive myopia impact a child’s vision, it can also increase their risk for pathologic conditions such as retinal detachment and glaucoma. The younger we diagnose and address the issue, the better the outcome.

  Source
• 

  Yue (Maria) Liu, OD, PhD

  Optometry; Myopia Control

  •

  UC Berkeley School of Optometry & Vision Science

  Myopia is irreversible, so we work to achieve a temporary correction and also slow down or prevent further progression.

  Source